UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032328
Receipt number R000036868
Scientific Title The anti-fatigue effects based on improvement of sleep by using mattress in children
Date of disclosure of the study information 2019/03/31
Last modified on 2018/04/20 14:32:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The anti-fatigue effects based on improvement of sleep by using mattress in children

Acronym

The anti-fatigue effects of mattress in children

Scientific Title

The anti-fatigue effects based on improvement of sleep by using mattress in children

Scientific Title:Acronym

The anti-fatigue effects of mattress in children

Region

Japan


Condition

Condition

Healthy child

Classification by specialty

Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the anti-fatigue effects based on sleep-improvement of mattress for children's daily life.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in sleep state, subjective fatigue, autonomic nerve function and cognitive function after 4-weeks intervention.

Key secondary outcomes

Amount of daily activity


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Sleep of test mattress for 4 weeks. / Wash out for 4 weeks. / Sleep of placebo mattress for 4 weeks.

Interventions/Control_2

Sleep of placebo mattress for 4 weeks. / Wash out for 4 weeks. / Sleep of test mattress for 4 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

9 years-old <=

Age-upper limit

12 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Healthy children from the 4th grade to 6th grade.
2.Children who can understand about this study and agree to participate in this study.

Key exclusion criteria

1.Children who take treatment.
2.Children who usually take medicines or supplements.
3.Children with medical history of cardiovascular disease or nervous system disease.
4.Children with allergy.
5.Children with insomnia.
6.Children who sleep with their family or pets on the same mattress.
7.Children who are judged not suitable to participate in this trial by investigators.

Target sample size

35


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kei Mizuno

Organization

Osaka City University

Division name

Center for Health Science Innovation

Zip code


Address

9F, Tower-C, Knowledge Capital, Grand Front Osaka, 3-1 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan.

TEL

+81-6-6485-0288

Email

chsi-b@ado.osaka-cu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kei Mizuno

Organization

Osaka City University

Division name

Center for Health Science Innovation

Zip code


Address

9F, Tower-C, Knowledge Capital, Grand Front Osaka, 3-1 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan.

TEL

+81-6-6485-0288

Homepage URL


Email

chsi-b@ado.osaka-cu.ac.jp


Sponsor or person

Institute

Osaka City University Center for Health Science Innovation

Institute

Department

Personal name



Funding Source

Organization

Nishikawa Living inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪市立大学健康科学イノベーションセンター(大阪府)


Other administrative information

Date of disclosure of the study information

2019 Year 03 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 04 Month 07 Day

Date of IRB


Anticipated trial start date

2015 Year 06 Month 27 Day

Last follow-up date

2015 Year 09 Month 19 Day

Date of closure to data entry

2015 Year 11 Month 04 Day

Date trial data considered complete

2016 Year 03 Month 14 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 04 Month 20 Day

Last modified on

2018 Year 04 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036868


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name